These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27884610)

  • 1. Impact of the Direct Oral Anticoagulants on Activated Clotting Time.
    Dincq AS; Lessire S; Chatelain B; Gourdin M; Dogné JM; Mullier F; Douxfils J
    J Cardiothorac Vasc Anesth; 2017 Feb; 31(1):e24-e27. PubMed ID: 27884610
    [No Abstract]   [Full Text] [Related]  

  • 2. Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment.
    Hakalahti A; Uusimaa P; Ylitalo K; Raatikainen MJ
    Europace; 2011 May; 13(5):640-5. PubMed ID: 21398311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation.
    Nagao T; Inden Y; Yanagisawa S; Kato H; Ishikawa S; Okumura S; Mizutani Y; Ito T; Yamamoto T; Yoshida N; Hirai M; Murohara T
    Heart Rhythm; 2015 Sep; 12(9):1972-8. PubMed ID: 25881495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total Thrombus-Formation Analysis System (T-TAS) Can Predict Periprocedural Bleeding Events in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
    Ito M; Kaikita K; Sueta D; Ishii M; Oimatsu Y; Arima Y; Iwashita S; Takahashi A; Hoshiyama T; Kanazawa H; Sakamoto K; Yamamoto E; Tsujita K; Yamamuro M; Kojima S; Hokimoto S; Yamabe H; Ogawa H
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26811167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Impact of Heparin Kinetics During Catheter Ablation of Atrial Fibrillation: Meta-Analysis and Meta-Regression.
    Briceno DF; Villablanca PA; Lupercio F; Kargoli F; Jagannath A; Londono A; Patel J; Otusanya O; Brevik J; Maraboto C; Berardi C; Krumerman A; Palma E; Kim SG; Natale A; DI Biase L
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):683-93. PubMed ID: 27004444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pre-interventional, peri-interventional and post-interventional anticoagulation in the setting of catheter ablation for atrial fibrillation : current practice and practical approach].
    Antz M; Willems S; Hoffmann BA
    Herz; 2015 Feb; 40(1):45-9. PubMed ID: 25645235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new generation of oral direct anticoagulants.
    Soff GA
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):569-74. PubMed ID: 22345595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the concomitant use of heparin on the effects of warfarin during catheter ablation for atrial fibrillation.
    Inada K; Matsuo S; Tokutake K; Yokoyama K; Hioki M; Narui R; Ito K; Tanigawa S; Yamashita S; Tokuda M; Shibayama K; Miyanaga S; Sugimoto K; Yoshimura M; Yamane T
    Heart Vessels; 2016 Mar; 31(3):397-401. PubMed ID: 25471944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of therapeutic INR on activated clotting times, heparin dosage, and bleeding risk during ablation of atrial fibrillation.
    Gautam S; John RM; Stevenson WG; Jain R; Epstein LM; Tedrow U; Koplan BA; McClennen S; Michaud GF
    J Cardiovasc Electrophysiol; 2011 Mar; 22(3):248-54. PubMed ID: 20812929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo effects of low-dose rivaroxaban on specific coagulation assays and coagulation factor activities in patients under real life conditions.
    Mani H; Hesse C; Stratmann G; Lindhoff-Last E
    Thromb Haemost; 2013 Jan; 109(1):127-36. PubMed ID: 23138190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of lower activated clotting times during atrial fibrillation ablation using open irrigated tip catheters and a single transseptal puncture.
    Winkle RA; Mead RH; Engel G; Patrawala RA
    Am J Cardiol; 2011 Mar; 107(5):704-8. PubMed ID: 21185007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New oral anticoagulants compared to warfarin for perioperative anticoagulation in patients undergoing atrial fibrillation catheter ablation: a meta-analysis of continuous or interrupted new oral anticoagulants during ablation compared to interrupted or continuous warfarin.
    Zhao Y; Yang Y; Tang X; Yu X; Zhang L; Xiao H
    J Interv Card Electrophysiol; 2017 Apr; 48(3):267-282. PubMed ID: 28078536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anticoagulants before and after ablation for atrial fibrillation.
    Verheugt FW; Khan M; De Ruiter GS; Riezebos RK
    Europace; 2010 Jul; 12(7):913-4. PubMed ID: 20530641
    [No Abstract]   [Full Text] [Related]  

  • 14. Quick reference guide to the new oral anticoagulants.
    Hurst K; Lee R; Handa A
    J Vasc Surg; 2016 Jun; 63(6):1653-7. PubMed ID: 27113315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periprocedural DOAC Anticoagulation Interruption Strategies for Atrial Fibrillation Ablation: Can a Physician Actually Choose the One They Like?
    Winkle RA
    JACC Clin Electrophysiol; 2018 Jun; 4(6):807-809. PubMed ID: 29929674
    [No Abstract]   [Full Text] [Related]  

  • 16. Low dose dabigatran versus uninterrupted acenocoumarol for peri-procedural anticoagulation in atrial fibrillation catheter ablation.
    Efremidis M; Vlachos K; Letsas KP; Giannopoulos G; Lioni L; Georgopoulos S; Vadiaka M; Deftereos S; Sideris A
    J Electrocardiol; 2015; 48(5):840-4. PubMed ID: 26152604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Searching for left atrial thrombi prior to catheter ablation of atrial fibrillation: are there patients who can safely avoid preablation transesophageal echocardiography?
    Cappato R
    J Cardiovasc Electrophysiol; 2009 Apr; 20(4):385-7. PubMed ID: 19054245
    [No Abstract]   [Full Text] [Related]  

  • 18. Editors' Choice papers in Thrombosis and Haemostasis.
    Weber C; Lip GY
    Thromb Haemost; 2015 Jan; 113(1):217-20. PubMed ID: 25567474
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonvitamin K antagonist oral anticoagulants (NOACs): the tide continues to come in.
    Blann A
    Vasc Health Risk Manag; 2015; 11():489-92. PubMed ID: 26316773
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral anticoagulant use around the time of atrial fibrillation ablation: a review of the current evidence of individual oral anticoagulant use for periprocedural atrial fibrillation ablation thromboembolic prophylaxis.
    Garton AB; Dudzinski J; Kowey PR
    J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1411-8. PubMed ID: 25216104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.